Mismatched Tech And Demand Behind Korea’s Slow Pharma AI Progress

'Trial And Error' Process

 
• By Jung Won Shin
  
artificial intelligence
South Korea’s AI Drug Development Still 'Immature' • Source: Alamy

More from South Korea

More from Focus On Asia